|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls000871105 |
| 003 |
SK-MaSNL |
| 005 |
20260304131006.0 |
| 008 |
250429c2004 xo 0 slo |
| 015 |
|
|
|a SNBRB2004/05-14378
|
| 035 |
|
|
|a CLN000222657
|
| 035 |
|
|
|a urn:nbn:sk:snk-ab6zae
|
| 035 |
|
|
|a (uuid)7d37d25f-bd1d-4421-bb4f-aa1e3c0fd543
|
| 035 |
|
|
|a (urnnbn)urn:nbn:sk:snk:ar-a06cae
|
| 035 |
|
|
|a (sysno)vtls000871105
|
| 040 |
|
|
|a SNKBUCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
0 |
|
|a eng
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 575.113:616.38
|2 1997
|
| 100 |
1 |
|
|a Nersesyan, A.K.
|4 aut
|9 1434492
|
| 245 |
1 |
0 |
|a Modification of clastogenesis and carcinogenesis in rats and mice by means of anthrax live vaccine
|c A.K. Nersesyan
|
| 300 |
|
|
|b Tab.
|
| 504 |
|
|
|a Res. angl.
|
| 504 |
|
|
|a Bibliogr. odkazy
|
| 650 |
0 |
7 |
|a mutagenéza
|2 SNKPH
|9 20126
|
| 650 |
0 |
7 |
|a cyklofosfamid
|x aplikácia a dávkovanie
|x použitie terapeutické
|2 MESH
|9 1443366
|
| 650 |
0 |
7 |
|a karcinogény
|2 MESH
|9 16270
|
| 650 |
0 |
7 |
|a vakcíny
|2 MESH
|9 16481
|
| 650 |
0 |
7 |
|a antrax
|2 MESH
|9 23041
|
| 650 |
0 |
7 |
|a mikrojadrá
|x genetika
|2 MESH
|9 1443367
|
| 650 |
0 |
7 |
|a genetika
|2 SNKPH
|9 698
|
| 655 |
|
7 |
|a články z novín a časopisov
|2 snkbucl
|9 267496
|
| 773 |
0 |
|
|t Neoplasma
|g Vol. 51, no. 1 (2004), p. 21-24
|x 0028-2685
|
| 850 |
|
|
|a Slovenská národná knižnica
|
| 852 |
|
|
|a Slovenská národná knižnica
|
| 958 |
|
|
|a article27
|
| 958 |
|
|
|a NB
|
| 958 |
|
|
|a MI
|
| 958 |
|
|
|a OND
|
| 958 |
|
|
|a EUIPO
|
| 992 |
|
|
|a RBX
|
| 999 |
|
|
|c 2895897
|d 2897827
|
